đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
Two doses each of Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rube...
Status
Completed
Location
Multiple Locations
Start Date
2007-03-26
Trial ID
NCT00326183
The purpose of this trial is to study the safety and immune response to mea...
Status
Completed
Location
Multiple Locations
Start Date
2001-12
Trial ID
NCT00092404
The study was conducted to determine if ProQuad may be used in place of the...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT00985166
The purpose of this study is to test the safety of a measles, mumps, and ru...
Status
Completed
Location
Multiple Locations
Start Date
2004-10
Trial ID
NCT00109278
The purpose of this study is to determine the mumps virus strength at the e...
Status
Completed
Location
Multiple Locations
Start Date
1999-02
Trial ID
NCT00092391
A Study comparing three different doses of ProQuad to concomitant administr...
Status
Completed
Location
Multiple Locations
Start Date
1999-04
Trial ID
NCT00986232
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
This study will compare Measles, Mumps, Rubella, and Varicella Vaccine (V22...
Status
Completed
Location
Multiple Locations
Start Date
1998-03
Trial ID
NCT00975507
The study is being conducted to demonstrate that V221 may be administered c...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00109343
This study will test the safety, tolerability, and immunogenicity of VARIVA...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00822237